Purinostat, CAS [[1929583-17-4]] Preis auf Anfrage

Catalog Number: TGM-T204269
Article Name: Purinostat, CAS [[1929583-17-4]] Preis auf Anfrage
Biozol Catalog Number: TGM-T204269
Supplier Catalog Number: T204269
Alternative Catalog Number: TGM-T204269-10MG,TGM-T204269-50MG
Manufacturer: TargetMol
Category: Biochemikalien
Purinostat is a selective inhibitor of HDACI/IIb with potential anti-leukemic properties. Its mesylate form, Purinostat mesylate, is effective at inhibiting the survival of Ph+ leukemic cells and CD34+ leukemic cells derived from CML patients. Purinostat mesylate targets HDACI/IIb, impacting several crucial factors for leukemia stem cell (LSC) survival, such as c-Myc, beta-Catenin, E2f, Ezh2, Alox5, and mTOR. Additionally, Purinostat mesylate enhances glutamate metabolism in LSCs by increasing GLS1.
Molecular Weight: 490.518
CAS Number: [1929583-17-4]
Formula: C23H26N10O3
Target: HDAC
T204269